Biden Administration introduces price regulation to the pharmaceutical industry.
Researchers explore the optimal cost-benefit considerations of medical device cybersecurity risks.
Experts discuss how regulators can protect consumers from aggressive collection practices.
Scholar argues that generational amnesia may lead to ineffective regulatory solutions in the future.
Scholar argues that FDA should adopt an evidenced-based approach to regulating drug manufacturers’ speech.
Scholar argues for greater privacy protections of personal medical data collected by wearable health technologies.
Scholars evaluate the impact of work requirements on Medicaid beneficiaries.
Merck misconstrues patent law in its recent Takings Clause challenge to Medicare’s price negotiation program.
Scholars advocate mandated patient access to health device data.
Scholars claim that unregulated wilderness therapy programs fail to protect the children participants.
Scholars propose enabling patients to sue the makers and providers of discriminatory health care algorithms.
Experts offer analysis and policy ideas to promote the independence and well-being of older adults.